Detalhe da pesquisa
1.
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.
Nature
; 620(7974): 651-659, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468627
2.
Stromal changes in the aged lung induce an emergence from melanoma dormancy.
Nature
; 606(7913): 396-405, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35650435
3.
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.
Mol Cell
; 77(3): 633-644.e5, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836388
4.
ClampFISH 2.0 enables rapid, scalable amplified RNA detection in situ.
Nat Methods
; 19(11): 1403-1410, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280724
5.
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.
Mol Cell
; 77(3): 681, 2020 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032511
6.
Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors.
bioRxiv
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168186
7.
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma.
Oncogene
; 43(6): 395-405, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066089
8.
Progress in melanoma treatment: Patient's perspectives.
Pigment Cell Melanoma Res
; 36(6): 594-601, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37819777
9.
Diversity, equity, and inclusion in the melanoma research community.
Pigment Cell Melanoma Res
; 36(5): 441-447, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37093838
10.
Age-related increases in IGFBP2 increase melanoma cell invasion and lipid synthesis.
bioRxiv
; 2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205503
11.
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas.
bioRxiv
; 2023 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36711814
12.
Disrupting cellular memory to overcome drug resistance.
Nat Commun
; 14(1): 7130, 2023 11 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932277
13.
Emerging strategies to treat rare and intractable subtypes of melanoma.
Pigment Cell Melanoma Res
; 34(1): 44-58, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274887
14.
Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.
Cancer Res
; 81(3): 658-670, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262126
15.
Genetic screening for single-cell variability modulators driving therapy resistance.
Nat Genet
; 53(1): 76-85, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33398196
16.
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
Cancer Res
; 81(20): 5230-5241, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462276
17.
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients.
Clin Cancer Res
; 26(21): 5709-5719, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097493
18.
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2.
Cancer Discov
; 10(9): 1282-1295, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499221
19.
Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis.
Cancer Discov
; 9(12): 1720-1735, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578185
20.
Author Correction: Disrupting cellular memory to overcome drug resistance.
Nat Commun
; 15(1): 4264, 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769307